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INTRODUCTION
Cardiovascular diseases (CVDs) are on the rise globally
and cause one-third of deaths worldwide, with 80%
of  such mortality in developing countries.1  The burden
of CVD is primarily driven by dyslipidemia,
hypertension, obesity, diabetes, physical inactivity, poor
diet, and smoking.1 The CVDs burden is anticipated
to burgeon in the coming years.2
Orofacial clefts (OFCs) or cleft lip and palate defects
are the commonest congenital malformation of  the
head & neck and one of the most frequent congenital
disabilities globally.3,4 The disorder is of  enormous
medical, surgical, or cosmetic importance in addition
to the colossal health care cost. They can occur as
syndromic or non-syndromic forms with the latter
being the more common.3, 4
The estimated prevalence of OFCs in Nigeria is about
0.5:1000 live births.5-7 It occurs in about 1 in 700 live
births globally while it accounted for 3,800 deaths
globally in 2017 or 3.8 per 100,000 person death from
the Global Burden of  Disease (GBD) 2017 estimates.8,9
Furthermore, the highest prevalence at birth of  OFCs
is among the native American and Asian (1 in 500 live
births), while the lowest prevalence is among the
populations of African descent, with approximately 1
in 2,500 live births.10
The usual male: female ratio was 2:1 in the various
OFC variants such as cleft lip and/or cleft lip and
palate.9 The Nigerian craniofacial anomalies study,
Nigeria CRAN, showed a male: female ratio of  1.19:1
of  all OFCs.7
Furthermore, cardiovascular anomalies are commonly
associated with OFCs and these associated
cardiovascular defects may require lifelong follow up
after corrective surgery for OFCs.11 Cardiovascular
diseases or cardiovascular risk factors and oro-facial
defects interplay may be a casual relation or a mere
association.
Pre-conceptional, as well as conceptional maternal
cardiovascular risk factors (CRFs) may predispose to
the development of  cleft palate in the offspring. Such
increased causality or the CRFs interlink with OFCs
may be the strong link to the possibility of reversal of
the epidemiological burden for OFCs or just the
continuous presence of cases as CVDs/CRFs are on
the increase. The key CRFs linked to OFCs includes
alcohol use, obesity and smoking with obesity and
smoking each having 6% population attributable risk
factors.11 Cardiovascular conditions in the form of
congenital heart diseases usually present alongside this
condition in newborns.
Cleft lip and/or cleft palate may arise in isolation or
association with a syndrome and CRFs, and Congenital
heart diseases(CHDs) are associated with both
syndromic and non-syndromic OFCs although
commoner in the former.4, 12
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There is a complex interplay between orofacial clefts (OFCs) or cleft of the lip
and palate and cardiovascular risk factors and cardiac diseases. The presence of
maternal cardiovascular risk factors serves as a potent predisposing factor to the
development of OFCs during foetal development in addition to the fact that
various congenital anomalies are associated with OFCs either in syndromic or
non-syndrome relationship. This article narratively explores this complex
interplay, which is not uncommon.
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Primordial: Predisposing Cardiovascular Risk
Factors
The development of OFCs in offspring is associated
with the presence of pre-conceptional maternal
cardiovascular risk factors particularly obesity, dietary
patterns, maternal hypertension, maternal diabetes
mellitus and smoking(passive and non-passive) (See
Table 1).10, 11, 13
A systematic review and meta-analysis of a collection
of data spanning forty-three years from North
America, Europe and Australia revealed a significant
association between maternal obesity, as measured by
the Body Mass Index (BMI), and having a pregnancy
complicated by cleft palate.14 Maternal obesity was
noted to lead to the development of foetal cleft palate
(OR, 1.23; 95% CI, 1.03-1.47; P=.02) or cleft lip and
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Table 1: Table highlighting studies demonstrating the link of  cardiovascular risk factors and OFCs
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palate (OR, 1.20; 95% CI, 1.03-1.40;P=.02)14 Other
studies also established the predisposition of maternal
diabetes mellitus to OFCs. A large study over a ten-
year period, among Swedish women, found a similar
result even after adjustment for year of  birth, parity,
maternal age, and maternal smoking.15 In this case,
however, the presence of another major co-existing
anomaly alongside cleft palate showed a stronger
association with obesity.15 Although the reason for this
association is unknown, it has been attributed to
undetected type 2 diabetes.15 (Table 1).16, 17
Maternal western dietary pattern during the
preconception period has also been shown to be a
risk factor. A case-control study among a female Dutch
population showed that diets rich in meat, pizza,
potatoes, legumes, French fries, and low in fruits were
shown to correlate with cleft palate in the offspring
when compared with diets associated with high intake
of  fish, vegetables, garlic and nuts.18 This is unconnected
with low maternal serum levels of vitamin B12 and
folic acid associated such diet.18
12, 19, 20, which reduces homocysteine level, although data
on the use of folic acid as supplement in prevention
of OFC is sparse.12 However, some studies have
revealed no association, while others have been
inconclusive.12, 21-23. Further studies are required to
associate hyperhomocysteinamia with coexistence of
cardiac diseases and OFC.
Pregestational diabetes mellitus is also a well-known
risk factor for cleft palate in the offspring.24, 25 In a
United States Natality database, a population-based
case-control study showed that diabetic mothers were
almost 1.4 times more likely to develop cleft palate
than non-diabetic mothers.15, 16, 26
Passive and active cigarette smoking in pregnancy has
been associated with the development of cleft palate.
The records of 3,891,494 live births from the 1996
U.S. Natality database showed this clear  predisposition
to OFCs using cases-controls design of maternal
smoking even after adjustment of confounding
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X-linked dominant atrial/ventricular septal
defect
CHARGE syndrome54 Mutation of CHD7 gene Tetralogy of Fallot, double
outlet right ventricle with
atrioventricular canal, patent
ductus arteriosus, ventricular
septal defect and atrial septal
defect with or without cleft
mitral valve
Table 2: OFCs Syndromes and some congenital cardiac anomalies
Hyperhomocysteinemia, which is associated with low
levels of folic acid, is a known risk factor for heart
disease.18 Similarly, studies have demonstrated an
association between hyperhomocysteinemia and cleft
palate18, while many studies have demonstrated the
beneficial effect of maternal folic acid supplementation
variables.27 There was a demonstrable dose-response
smoking risk for OFCs in first trimester especially with
combined defect of both lips and palate rather than
solitary defects.27-29 The link with alcohol intake,
particularly in the first trimester, may not be
unconnected with retinoic acid production.28, 29 Unlike
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der Woude syndrome.4 Some genetic mutations like
that in TGFBR1 or TGFBR2 genes have also been
reported to cause combined cleft palate and
cardiovascular disease (Table 3).36
Orofacial Defects, Paediatric Cardiologist, and
the Adult Cardiologist
Even though an affected child may benefit form repair
of the defect within a year of birth, such care may not
be available in a resource-poor environment like
Nigeria especially in situation of non-assess to free
treatment intervention such as SMILE programme.37,38
Furthermore, it may come with a severe attendant
implication which is beyond the primary care specialist
that may have initially intervened. Those issues associated
with OFCs may not be the initial interest of the parents
and caregivers, rather the orofacial defect that pose a
severe cosmetic problem. Some of the cardiovascular
diseases may linger into adulthood with attendant
mortality and morbidity which undermine the quality
of  life. For example, in Loeys-Dietz Syndrome, the
OFC may be repaired while leaving a risk of
widespread and aggressive arterial aneurysms later in
childhood or adulthood.39
the smoking exposure, the association of alcohol intake
with OFC is not dose responsive.28
Generally, various cardiovascular risk factors are inter-
related. Western dietary patterns could predispose to
obesity, and obesity may be an early pointer to diabetes
mellitus. Therefore, there may be an underlying,
undiagnosed impaired glucose tolerance in these
populations that were studied, which most studies did
not take into account. While some studies identified
the role of maternal alcohol intake during pregnancy
on OFCs, many are frosted by small sample sizes. Also
implicated are hypertension and the usage of
antihypertensive drugs10, 30
Finally, cardiovascular diseases appear to be more
common in the cleft palate than cleft lip,23,27 but more
studies are required to confirm these.
Associations of Orofacial Defects and
Cardiovascular Diseases
Congenital heart disease is the most frequent associated
anomaly in patients with cleft palate as shown in
various studies3, 6, 31, with atrial septal defect31, 32 often
being cited. Others include patent ductus arteriosus,









Interrupted aortic arch type B, truncus arteriosus,
tetralogy of Fallot, pulmonary atresia with ventricular
septal defect, pulmonary atresia with a ventricular
septal defect
Edward syndrome57 Sporadic, Trisomy 18 Ventricular septal defect, Patent ductus arteriosus,
transposition of great arteries, pulmonary atresia
Patau syndrome58 Sporadic, Trisomy 13 Ventricular septal defect, atrial septal defect, Patent
ductus arteriosus
Table 3: Orofacial clefts and chromosomal anomalies
pulmonary stenosis, tetralogy of  Fallot and ventricular
septal defect.33 There is a wide variation of the incidence
and prevalence of congenital heart disease among
neonates with cleft palate.7,34 The risk of having a
congenital heart disease have been reported to be 23
times that of the general population.33
Cardiovascular disease and cleft palate can be present
in conditions that can affect multiple organ systems,
for example, in chromosomal defects like Edward
syndrome (Trisomy 18) and Patau syndrome (Trisomy
13) particularly in the non-isolated cleft palate (Table
3).25 They can both be significant components in
sequences and syndromes, notably Velocardiofacial
syndrome,4, 35 DiGeorge syndrome,35 and rarely, Van
Therefore, the excellent prognosis is underpinned not
only by the initial management but also care and regular
follow-up by an experienced interdisciplinary team
from infancy until adulthood.
CONCLUSION
Cardiovascular diseases and cleft palate interrelate in
various ways; although the mechanisms are unclear,
more studies are required to reveal more associations.
There is currently enough evidence that maternal
cardiovascular risk factors are potent risk factors for
foetal OFCs development in addition to the fact that
many congenital heart diseases are associated with
OFCs.
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